Autoreceptor preference of dopamine D2 receptor agonist correlates with preferential coupling to cyclic AMP

被引:5
|
作者
Mercier, D
Falardeau, P
Lévesque, D
机构
[1] CHU Laval, CHUQ Res Ctr, Neurosci Unit, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Fac Med, Dept Med, Quebec City, PQ G1K 7P4, Canada
[3] Univ Laval, Fac Pharm, Quebec City, PQ G1K 7P4, Canada
关键词
adenylate cyclase; autoreceptor functions; cyclic AMP; dopamine D-2 receptor; dopamine release; dopamine synthesis; inositol triphosphate; locomotor inhibition; phospholipase C;
D O I
10.1097/00001756-200105250-00036
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopamine autoreceptors control the synaptic release and turnover of dopamine. Some dopamine agonists display a preference for modulation of autoreceptor functions rather than postsynaptic-driven behaviors. However, the nature of this apparent selectivity is still elusive. To investigate this property, we have used an heterologous expression system in which D-2S receptors are coupled to both inhibition of cyclic AMP levels and stimulation of inositol triphosphate production. We show that D-2-like receptor agonists display distinct potencies on these two second messenger pathways; Moreover, a strong correlation is observed between the potency of agonists to interact with adenylate cyclase and their potency to modulate autoreceptor functions. Such a correlation does not show up with the phospholipase C pathway. This suggests that autoreceptor preference of D-2-like receptor agonists may be driven by a preferential interaction with a second messenger system. NeuroReport 12:1473-1479 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:1473 / 1479
页数:7
相关论文
共 50 条
  • [1] Development of a Bivalent Dopamine D2 Receptor Agonist
    Kuehhorn, Julia
    Goetz, Angela
    Huebner, Harald
    Thompson, Dawn
    Whistler, Jennifer
    Gmeiner, Peter
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (22) : 7911 - 7919
  • [2] PET evaluation of the dopamine D2 receptor agonist
    Finnem, SJ
    Seneca, N
    Gulyas, B
    Sovago, J
    Farde, L
    Innis, RB
    Wikstrom, HV
    Halldin, C
    [J]. NEUROIMAGE, 2004, 22 : T175 - T175
  • [3] Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic
    Keck, PE
    McElroy, SL
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (04) : 655 - 662
  • [4] Discovery of a true bivalent dopamine D2 receptor agonist
    Qian, Mingcheng
    Ricarte, Adrian
    Wouters, Elise
    Dalton, James A. R.
    Risseeuw, Martijn D. P.
    Giraldo, Jesus
    Van Calenbergh, Serge
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 212
  • [5] VANADATE INHIBITS AGONIST BINDING TO D2 DOPAMINE RECEPTOR
    ELAZAR, Z
    FUCHS, S
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 1991, 3 (01) : 1 - 6
  • [6] The Dopamine Transporter and D2 Autoreceptor Drive Local Differences in Dopamine Release
    Verharen, Jeroen
    de Jong, Johannes
    Lu, Odilia
    Quintana, Clementine
    Rajakrishna, Lakshmi
    Beaulieu, Jean-Martin
    Lammel, Stephan
    [J]. NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 488 - 488
  • [7] Modeling of Dopamine D2 Receptor and its Agonist DOCK Analyses
    朱七庆
    郭宗儒
    [J]. Journal of Chinese Pharmaceutical Sciences, 1998, (03) : 3 - 8
  • [8] Aripiprazole acts as a selective dopamine D2 receptor partial agonist
    Wood, Martyn
    Reavill, Charlie
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (06) : 771 - 775
  • [9] Inverse agonist profiling of antipsychotics at the human D2 dopamine receptor
    Burstein, ES
    Ma, J
    Wong, S
    Weiner, DM
    Brann, MR
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 509 - 509
  • [10] AMP-activated protein kinase slows D2 dopamine autoreceptor desensitization in substantia nigra neurons
    Yang, Wei
    Munhall, Adam C.
    Johnson, Steven W.
    [J]. NEUROPHARMACOLOGY, 2019, 158